Hints and tips:
Related Special Reports
...Soriot’s remuneration was already “competitive against European peers”, it added in a report, a copy of which was seen by the Financial Times....
...“If you look at how we are scaling up API capacity, we’re scaling to serve many more patients,” he said. “The more we go oral, the less we can give injectables.”...
...Soriot’s pay package has proved a lightning rod for investors in the past....
...In recommending that investors oppose the plans, ISS said it acknowledged that AstraZeneca, the UK’s second-largest public company by market value, has “a global reach, is in a high-paying sector, with a...
...The bill labels Shanghai-based WuXi AppTec “a biotechnology company of concern”, which is described as any entity posing a risk to the US by engaging in joint research with a foreign adversary’s military...
...“What we’re trying to do is give the liver a little nudge in the right direction to support it to regenerate,” said Quin Wills, chief scientific officer and co-founder of Ochre Bio....
...Since his diagnosis for bladder cancer in 2019, Michael Caratti says he has undergone “a 180 degree change in my life”....
...It recently sold a large site in California to contract manufacturer Lonza for $1.2bn....
...These price concessions increased from 20 instances per month before 2016 to a peak of 199 per month in late 2022....
...The European Commission is the first authority to approve the treatment, which is likely to be used in a relatively narrow group of serious cases to reduce the risk it will trigger a surge in anti-microbial...
...“This is not a problem just for the heroin users. This is a problem for a wider population of people who use drugs, who might not think that they’re at risk of xylazine harm,” she added....
...The question will be discussed in a parallel trial starting in May....
...There were 26 inspection refusals last year, down from a peak of 62 in 2022 “When you talk about antibiotics, the Chinese are in a very critical position as most of the starting materials for antibiotics...
...“We’re well positioned to be leaders in the broader field [of radioconjugates].”...
...“The whole system has a just-in-time principle and any rupture in that causes a downstream shortage,” says Rob Moss, a hospital pharmacy consultant in Utrecht, the Netherlands....
...Like many European pharmaceutical companies, it makes a large proportion of sales in the US....
...Soriot would also be in line for a bonus worth up to 300 per cent of his base salary, compared with the prior policy of 250 per cent. Read more here...
...“We’re about 20 years behind cancer,” she said....
...in survival in this setting, marking a breakthrough for patients”....
...The company will increase its footprint at a Cambridge biomedical site and build a vaccine manufacturing site in Speke in Liverpool....
...Shareholders will vote later today on a plan to raise Soriot’s pay by £1.8mn to a maximum of £18.7mn in 2024....
...Novo Nordisk purchased Dicerna Pharmaceuticals, a company focused in RNA-based therapeutics, for $3.3bn in 2021....
...The funds have been awarded by the British Business Bank, a state-owned lender.The money is part of the government’s ambition to encourage pension schemes to invest more in unlisted UK companies....
...“Growth companies tend to prefer US markets, particularly in healthcare. They’re going with the flow,” he added....
...The first approved medicine for a rare and fatal genetic disorder in children, metachromatic leukodystrophy, this week became the most expensive drug in history, pricing at $4.25mn....
International Edition